Skip to content

MONO-VIDITEST anti-HSV 1+2 IgG

by VIDIA spol. s r.o. EUDAMED

Active European Union

Ref KZ-140-12Model MONO-VIDITEST anti-HSV 1+2 IgG

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-38594036041401 Basic UDI-DIDate10 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

No notified-body certificate is listed. Devices of this class are self-declared by the manufacturer.

Specification

EUDAMED

Model / Reference
MONO-VIDITEST anti-HSV 1+2 IgG, KZ-140-12
Primary DI / UDI-DI
38594036041401
Basic UDI-DI
B-38594036041401
EMDN Code
W0105040303 Hsv 1+2 igg
Device Class
Class IVD General
Market of Registration
Czechia

Manufacturer details

EUDAMED SRN
CZ-MF-000036964

Other devices from VIDIA spol. s r.o.

See all devices from VIDIA spol. s r.o. →

Properties

  • Human Tissues
  • Microbial Substances
  • Professional Testing

Other properties (7)

  • Sterile: No
  • Animal Tissues: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No